Why Invest In Plus Therapeutics Inc (PSTV) Stock?

Plus Therapeutics Inc (NASDAQ:PSTV) has a beta value of 0.64 and has seen 6.43 million shares traded in the last trading session. The company, currently valued at $18.34M, closed the last trade at $0.36 per share which meant it gained $0.01 on the day or 2.48% during that session. The PSTV stock price is -541.67% off its 52-week high price of $2.31 and 55.56% above the 52-week low of $0.16. If we look at the company’s 10-day average daily trading volume, we find that it stood at 20.21 million shares traded. The 3-month trading volume is 26.85 million shares.

Plus Therapeutics Inc (NASDAQ:PSTV) trade information

Sporting 2.48% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the PSTV stock price touched $0.36 or saw a rise of 5.26%. Year-to-date, Plus Therapeutics Inc shares have moved -76.64%, while the 5-day performance has seen it change 21.36%. Over the past 30 days, the shares of Plus Therapeutics Inc (NASDAQ:PSTV) have changed 2.80%. Short interest in the company has seen 1.17 million shares shorted with days to cover at 0.1.

Plus Therapeutics Inc (PSTV) estimates and forecasts

The company’s shares have lost -70.99% over the past 6 months.

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 46.51% over the past 5 years. Earnings growth for 2025 is a modest 66.32% while over the next 5 years, the company’s earnings are expected to increase by 49.58%.

PSTV Dividends

Plus Therapeutics Inc is expected to release its next earnings report on 2025-May-30 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.

Plus Therapeutics Inc (NASDAQ:PSTV)’s Major holders

Insiders own 2.02% of the company shares, while shares held by institutions stand at 2.50% with a share float percentage of 2.55%. Investors are also buoyed by the number of investors in a company, with Plus Therapeutics Inc having a total of 17.0 institutions that hold shares in the company. The top two institutional holders are AIGH CAPITAL MANAGEMENT LLC with over 0.57 million shares worth more than $0.84 million. As of 2024-06-30, AIGH CAPITAL MANAGEMENT LLC held 8.7478% of shares outstanding.

The other major institutional holder is GEODE CAPITAL MANAGEMENT, LLC, with the holding of over 46648.0 shares as of 2024-06-30. The firm’s total holdings are worth over $68572.0 and represent 0.7176% of shares outstanding.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.